Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0040586 (
tracheobronchitis
)
449
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two young children inhaled sweets which dissolved in the tracheobronchial secretions and caused severe respiratory obstruction. The viscid fluid produced as the sweet dissolved was not expectorated and bronchoscopy was necessary. The oedema of the mucosa caused by the presence of a hyperosmolar sugar solution took up to 48 hours to resolve; antibiotics and steroid cover were considered necessary. The similarity of presentation with acute
tracheobronchitis
and the lack of reports in the literature suggest that such cases may be misdiagnosed.
Thorax
1975 Aug
PMID:Dissolving foreign bodies in the trachea and bronchus. 117 31
A lifelong non-smoker who was the victim of a massive accidental exposure to anhydrous ammonia gas was followed up for 10 years. In the acute phase the patient presented with severe
tracheobronchitis
and respiratory failure, caused by very severe burns of the respiratory mucosa. After some improvement he was left with severe and fixed airways obstruction. Isotope studies of mucociliary clearance, computed tomography, and bronchography showed mild bronchiectasis. It is concluded that acute exposure to high concentrations of ammonia may lead to acute respiratory injury but also to long term impairment of respiratory function.
Thorax
1992 Sep
PMID:Acute and long term respiratory damage following inhalation of ammonia. 144 Apr 75
Tracheobronchitis
and oesophagitis due to herpes simplex virus (HSV) are rare. Tracheo-oesophageal fistula due to HSV oesophagitis has been described in the immunocompromised host. A case is reported of a broncho-oesophageal fistula which developed secondary to herpetic bronchitis in an apparently immunocompetent patient.
Thorax
1995 Aug
PMID:Herpetic bronchitis with a broncho-oesophageal fistula. 757 Apr 46
Unilateral wheeze in the immunocompromised patient with unremitting fever may be the first localising sign of aspergillus
tracheobronchitis
. Two such cases are presented.
Thorax
1993 Dec
PMID:Unilateral wheeze caused by pseudomembranous aspergillus tracheobronchitis in the immunocompromised patient. 830 43
Invasive aspergillosis is a serious opportunistic infection in immunocompromised patients. The case history is described of a 44 year old patient with peripheral T cell lymphoma who developed hoarseness and stridor after chemotherapy. Aspergillus fumigatus was isolated repeatedly from the sputum. Bronchoscopic examination showed symmetrical creamy-white exophytic lesions involving both vocal cords and the supraglottic area. There was diffuse
tracheobronchitis
with multiple raised cream-coloured plaques in the trachea which histologically consisted of numerous septate branching hyphae consistent with Aspergillus species. The lesions responded to systemic treatment with amphotericin B.
Thorax
1996 Aug
PMID:Aspergillus laryngotracheobronchitis presenting as stridor in a patient with peripheral T cell lymphoma. 879 83
A case of aspergillus
tracheobronchitis
following influenza A infection in an immunocompetent 35 year old woman is described that required prolonged mechanical ventilation for airways obstruction. Treatment included liposomal amphotericin, inhaled amphotericin, gamma interferon and GM-CSF. Liposomal amphotericin therapy was associated with reversible hepatosplenomegaly. Inhaled corticosteroids with continued antifungal therapy were used for the management of severe recurrent airway obstruction. After a prolonged course of treatment she survived with fixed airways obstruction unresponsive to corticosteroids.
Thorax
1999 Nov
PMID:Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSF. 1052 67